U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417774) titled 'Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic' on Feb. 09.
Brief Summary: The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.
Study Start Date: Dec. 08, 2025
Study Type: OBSERVATIONAL
Condition:
Glioblastoma (GBM)
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: NuvOx LLC
Published by HT Digital Content Services with permission from Health Daily Digest....